{
    "Trade/Device Name(s)": [
        "GDH Professional Blood Glucose Monitoring System",
        "GDH Professional LED Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Infopia Co., Ltd.",
    "510(k) Number": "K150274",
    "Predicate Device Reference 510(k) Number(s)": [
        "K132966"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "July 22, 2015",
    "Summary Letter Received Date": "July 27, 2015",
    "Submission Date": "August 24, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GDH Professional meter",
        "GDH Professional LED meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test strip",
        "Control solution"
    ],
    "Document Summary": "FDA 510(k) summary for GDH Professional and GDH Professional LED Blood Glucose Monitoring Systems for quantitative measurement of glucose in whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in capillary and venous whole blood from multiple sites for professional multiple-patient use to aid in monitoring diabetes control, not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}